D
4576
vs
C
CANF
D
4576
C
CANF
Over the past 12 months, D.Western Therapeutics Institute Inc has significantly outperformed CANF, delivering a return of -14% compared to the CANF's 88% drop.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
4576
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
D
Intrinsic Value
75.86
JPY
Overvaluation 27%
C
CANF
Intrinsic Value
Not Available
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc
TSE:4576
|
104
JPY
|
|||||
|
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
708
ILS
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
4576, CANF
4576, CANF
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
D
|
D.Western Therapeutics Institute Inc
Revenue
|
|||||||||||
|
C
|
Can Fite Biopharma Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
4576, CANF
4576, CANF
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
D
|
D.Western Therapeutics Institute Inc
TSE:4576
|
|||||||||
|
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
D.Western Therapeutics Institute Inc
90%
CANF
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
Operating Margin
D.Western Therapeutics Institute Inc
-159.9%
CANF
-1 487.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
Net Margin
D.Western Therapeutics Institute Inc
-163.1%
CANF
-1 456.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
FCF Margin
D.Western Therapeutics Institute Inc
-128.1%
CANF
-953.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
ROE
D.Western Therapeutics Institute Inc
-58.3%
CANF
-382.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
ROA
D.Western Therapeutics Institute Inc
-32.9%
CANF
-187%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
ROIC
D.Western Therapeutics Institute Inc
-123.9%
CANF
-6 189.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
ROCE
D.Western Therapeutics Institute Inc
-35.4%
CANF
-273.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
C
|
Can Fite Biopharma Ltd | ||||
Solvency Comparison
D
D.Western Therapeutics Institute...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
4576, CANF
4576, CANF
Performance By Year
4576, CANF
4576, CANF
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 4576 to other stocks
PNEXF
Pharnext SCA
More expensive
vs D.Western Therapeutics Institute Inc
ABBV
Abbvie Inc
Cheaper
vs D.Western Therapeutics Institute Inc
ATXS
Astria Therapeutics Inc
More expensive
vs D.Western Therapeutics Institute Inc
AMGN
Amgen Inc
Cheaper
vs D.Western Therapeutics Institute Inc
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
